Symbiotec Pharmalab IPO fully subscribed on day 3, NIIs bid 5.58x
The initial public offering of Symbiotec Pharmalab, a pharmaceutical ingredient manufacturer, was fully subscribed on the third day of bidding on Wednesday. Non-institutional investors led demand with 5.58 times the shares set…
